STAT+: Can buying a drug patent application be seen as a bid to prolong a monopoly?
A drug patent case involving Amgen is being closely watched given its potential implications for pharmaceutical patent deals broadly.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.